Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Herd immunity wikipedia , lookup
Behçet's disease wikipedia , lookup
Ulcerative colitis wikipedia , lookup
Vaccination wikipedia , lookup
Globalization and disease wikipedia , lookup
Germ theory of disease wikipedia , lookup
Multiple sclerosis research wikipedia , lookup
Infection control wikipedia , lookup
IBD SSHAMP Inflammatory Bowel Disease Supported, Self Help And Management Programme Dr. Matt W. Johnson Backgound • The L&D Hospital catchment = 330,000 • No. of IBD = 2842 • Each are seen approx 1-2 x / year • Since 2006 - 440 on PSMPs New Challenges • 2008 National IBD Audit – Major regional differences in IBD service provision • 2009 IBD National Standards (BSG) – Minimum standards of care. • 2010 ECCO (European Crohn’s and Colitis Organisation) + BSG guidelines – New immunity assessment and management protocol • Patient Satisfaction Surveys • QUIPP - major drive to provide community based self management care IBD-SSHAMP • a) Functional Database - IBD-DR • b) Communication • - PKB Patient Portal c) Distance Monitoring - Virtual OPA+Calprotectin a) National IBD - DR Data is uploaded locally Every patient is listed Aspects are pooled Nationally Benefits Instant patient letters Generates worklists Generates reminders Enables analysis of any data-subsets b) Patient Knows Best Communication portal between patient and specialists (+/- GPs) Health passport Personalised management plans Library of advice sheets Disease activity assessment Targeted management advice Specialist overview from a distance c) Virtual Clinics + Calprotectin • Telephone clinic 1-2x / year • Automated testing + Reminders on IBD-DR – – – – – – Disease activity Blood tests Bone density Colonoscopy surveillance Faecal calprotectin Immunity assessments 1-2 x / year 1-2 x / year 1 x / 2-3 years 1,3 or 5 years 1-2 x / year 1 x / year Vaccinations • NB - Faecal Calprotectin 93% sensitive and 96% specific at differentiating between Functional and Organic bowel disease (MBJ Meta-anaysis. 2010;341:c3369) • Calprotectin can be used to predict a flare as the levels rise 2-3m before the symptomatic flare occurs (Tibble J. Gastro. 2000; 119:15-22). Clinical Benefits Reduce Flare ups Hospital attendance and admission Negative impact on daily activities eg. work Opportunistic infection rate Surgical complications rate Morbidity and mortality Improve Patient satisfaction Disease monitoring Access to specialist advice Empower patients Confidence and knowledge to self manage Overview of community management Financial Benefits Reduce GP clinic visits Hospital clinic visits Unnecessary radiological procedures Unnecessary colonoscopies performed Hospital admissions Surgical interventions. Improve Vaccination rates Cost, Sustainability and Dissemination Cost IBD - DR PKB Calprotectin IBD Nurse = £5,000 ? = £5,000 ? = £15,000 = £40,000 Total = 65,000 Savings OPAs 800 x1.5 x £87 = £104,400 Saved colonoscopies = £50,000 – ? Preventing hospital admissions, GP visits, surgery, opportunistic infections etc. Total = £154,400 + Graham Holland’s ‘the optimism and the frustration of living in a metropolis’